Topics

New antibiotic for drug-resistant tuberculosis scores FDA approval

11:01 EDT 15 Aug 2019 | MedCity News

The drug was developed by the non-profit TB Alliance. Some experts have said nonprofit organizations may provide a long-term solution to the growing problem of antibiotic resistance.

Original Article: New antibiotic for drug-resistant tuberculosis scores FDA approval

NEXT ARTICLE

More From BioPortfolio on "New antibiotic for drug-resistant tuberculosis scores FDA approval"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...